尼莫地平治疗脑出血后缺血性脑损害的临床探析  

Clinical Study on Nimodipine Medication Treatment of Ischemic Brain Damage After Cerebral Hemorrhage

作　　者：谭智芳 

机构地区：[1]黑龙江省齐齐哈尔市富裕县中医院,161200

出　　处：《中国卫生标准管理》2015年第11期78-79,共2页China Health Standard Management

摘　　要：目的：对尼莫地平治疗脑出血后缺血性脑损害的临床效果进行分析探究。方法选取于2014年3月～2014年12月在我院接受治疗的44例脑出血后缺血性脑损害患者，按照住院单双号随机分为两组，对依达拉奉和尼莫地平治疗的临床效果进行对照研究。结果治疗组患者的原发病灶缺血体积以及NIHSS评分和BI评分均优于对照组，差异有统计学意义（P〈0.05）。结论尼莫地平治疗脑出血后缺血性脑损害具有显著的临床效果，能够大大改善患者的神经功能缺损情况，对改善患者预后以及提高患者的生活质量具有十分重要的作用，在脑出血后缺血性脑损害疾病的临床治疗中有极高的应用价值。Objective Clinical effect on nimodipine medication in treatment of ischemic brain damage after cerebral hemorrhage is to be studied. Methods We chose 44 patients of ischemic brain damage after cerebral hemorrhage that were treated in hospital from March 2014 to December 2014 and separated them into two groups according to their hospitalization date number（odd number and even number）at random which were given edaravone and nimodipine medication treatment respectively and then made a comparative study on medication effects between two groups. Results Patients’ischemia volume of primary lesions and NIHSS scores and BI scores in study group were much more favorable than counterparts in control group,there was a differential between two groups and such a differential has statistic value（P〈0.05）. Conclusion Nimodipine medication is of clinical efficacy in treatment of ischemic brain damage after cerebral hemorrhage,it is conducive to improving patients’neurological function damage and patients’prognosis,besides,it is significant to promote patients’quality of life,thus,such a medication treatment is of application value in clinical treatment of ischemic brain damage after cerebral hemorrhage.

关 键 词：尼莫地平 脑出血 缺血性脑损害 

分 类 号：R972[医药卫生—药品]